1ST Source Bank’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-7,416
Closed -$531K 230
2016
Q4
$531K Sell
7,416
-1,090
-13% -$81K 0.05% 145
2016
Q3
$673K Buy
8,506
+1,318
+18% +$107K 0.07% 133
2016
Q2
$600K Buy
7,188
+4,585
+176% +$407K 0.07% 135
2016
Q1
$239K Buy
+2,603
New +$235K 0.03% 200
2015
Q4
Sell
-13,958
Closed -$1.37M 233
2015
Q3
$1.37M Buy
13,958
+10,489
+302% +$1.16M 0.16% 87
2015
Q2
$407K Buy
+3,469
New +$379K 0.04% 174
2014
Q4
Sell
-2,322
Closed -$247K 224
2014
Q3
$247K Buy
+2,322
New +$227K 0.03% 186

Other funds holding GILD

1ST Source Bank's GILD Position: Q1 2017 in Review

1ST Source Bank sold out of Gilead Sciences (GILD) in Q1 2017, closing a stake of 7,416 shares — an estimated $531K sold.

1ST Source Bank first reported a position in GILD in Q3 2014 and held it in 7 quarters. The position peaked at $1.37M in Q3 2015. 1,524 funds tracked by Wall St. Rank hold GILD as of Q1 2017.

  • 1ST Source Bank reported no remaining Gilead Sciences position as of Q1 2017 after selling out during the quarter.
  • 1ST Source Bank sold 7,416 Gilead Sciences shares in Q1 2017, an estimated $531K.
  • 1ST Source Bank first reported a position in Gilead Sciences in Q3 2014 and held it in 7 quarters.
  • 1ST Source Bank's Gilead Sciences position peaked at $1.37M in Q3 2015.
  • 1,524 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2017.

Based on 1ST Source Bank's 13F filing for Q1 2017, filed 26 Apr 2017.